From: Implementation by simulation; strategies for ultrasound screening for hip dysplasia in the Netherlands
Group
Cost-effectiveness range
CE_A low
3231 - 3469
CE_B moderate
3473 - 4188
CE_C intermediate
4190 - 4549
CE_D high
4794 - 5310